Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
|Articles|March 2, 2017
AbbVie Contract Manufacturing
Advertisement
AbbVie’s Contract Manufacturing business has been serving our partners for over 35 years. Our contract/toll development and manufacturing capabilities span Fermentation, Drug Product, Potent, Hot Melt Extrusion, Prefilled Syringes, Biologics, and Bulk Active Pharmaceutical Ingredients (APIs) across 10 production facilities in
North America and Europe.
1401 Sheridan Rd, North Chicago, IL 60064
[email protected]
tel. 1.847.938.8524
Advertisement
Related to this article
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
Advertisement
Advertisement